These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS. Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500 [Abstract] [Full Text] [Related]
47. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia. Palazzuoli A, Silverberg DS, Calabrò A, Spinelli T, Quatrini I, Campagna MS, Franci B, Nuti R. J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052 [Abstract] [Full Text] [Related]
49. The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. Broch K, Askevold ET, Gjertsen E, Ueland T, Yndestad A, Godang K, Stueflotten W, Andreassen J, Svendsmark R, Smith HJ, Aakhus S, Aukrust P, Gullestad L. PLoS One; 2014 Jun; 9(2):e89732. PubMed ID: 24586994 [Abstract] [Full Text] [Related]
50. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Mozaffarian D, Minami E, Letterer RA, Lawler RL, McDonald GB, Levy WC. Am J Cardiol; 2005 Dec 15; 96(12):1699-704. PubMed ID: 16360360 [Abstract] [Full Text] [Related]
51. Statins for ischemic systolic heart failure. Masoudi FA. N Engl J Med; 2007 Nov 29; 357(22):2301-4. PubMed ID: 17984167 [No Abstract] [Full Text] [Related]
55. The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk. Schuster H. Expert Rev Cardiovasc Ther; 2007 Mar 29; 5(2):177-93. PubMed ID: 17338663 [Abstract] [Full Text] [Related]
56. Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study). Wiviott SD, Mohanavelu S, Raichlen JS, Cain VA, Nissen SE, Libby P. Am J Cardiol; 2009 Jul 01; 104(1):29-35. PubMed ID: 19576317 [Abstract] [Full Text] [Related]
57. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P, CORONA Study Group. Eur Heart J; 2012 Sep 01; 33(18):2290-6. PubMed ID: 22513778 [Abstract] [Full Text] [Related]
59. Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes. Betteridge DJ, Gibson JM. Diabet Med; 2007 May 01; 24(5):541-9. PubMed ID: 17367312 [Abstract] [Full Text] [Related]
60. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA. Circulation; 2008 Mar 04; 117(9):1189-200. PubMed ID: 18285565 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]